- ledipasvir interMediate
-
- $1.10 / 1g
-
2022-05-23
- CAS:1441670-89-8
- Min. Order: 1g
- Purity: 99.0% Min
- Supply Ability: 100 Tons
|
| tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl) Basic information |
Product Name: | tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl) | Synonyms: | (6S)-6- [5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-IH-imidazol-2-yll-5-azaspiro;(S)-tert-butyl 6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;5-Azaspiro[2.4]heptane-5-carboxylic acid, 6-[5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl]-, 1,1-diMethylethyl ester, (6S)-;(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester;(6S)-tert-butyl-6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;InterMediate of Ledipasvir;(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylester;Ledipasvir INT 3 | CAS: | 1441670-89-8 | MF: | C27H26BrF2N3O2 | MW: | 542.41 | EINECS: | 939-899-8 | Product Categories: | | Mol File: | 1441670-89-8.mol | |
| tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl) Chemical Properties |
Boiling point | 681.1±55.0 °C(Predicted) | density | 1.53±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | pka | 11.13±0.10(Predicted) |
| tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl) Usage And Synthesis |
Uses |
Tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl) is the key intermediate that could be used to synthesize Ledipasvir which is a direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
|
| tert-Butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl) Preparation Products And Raw materials |
|